Advertisement
Obstetrics/Gynecology
Subscribe to Obstetrics/Gynecology

The Lead

How Do We Make the Breast Pump ‘Not Suck’?

October 23, 2014 10:28 am | by Melissa Barnes, Associate Editor | Blogs | Comments

When I read the recent news item about MIT’s “Make the Breast Pump Not Suck Hackathon,” I thought it couldn’t have come at a more relevant time in my life. Having just had a baby under seven months ago, and trying to continue a regular...

Photos of the Day: 'Hacking' the Breast Pump

October 17, 2014 12:23 pm | by MIT News | News | Comments

Over the course of a weekend, some 150 engineers, designers, developers, and health care...

Building a Better Mousetrap…er, Breast Pump

October 17, 2014 12:14 pm | by Cara Giaimo, MIT News correspondent | News | Comments

A few weekends ago, as some techies lined up to buy the new iPhone 6, others flocked to the MIT...

More Accurate Tests to Determine Ovarian Cancer Treatment

October 16, 2014 11:03 am | by Sam Wong, Imperial College London | News | Comments

Researchers have devised a new test to help doctors diagnose ovarian tumors and choose the most...

View Sample

FREE Email Newsletter

Complications & Costs – Bad News for Robotic Surgery Device Manufacturers

October 8, 2014 2:03 pm | by Columbia University Medical Center | News | Comments

For benign gynecologic conditions, robot-assisted surgery involves more complications during surgery and may be significantly more expensive than conventional laparoscopic surgery, according to a study by researchers at Columbia University...

Pediatricians Urge IUDs or Implants for Teen Girls

September 30, 2014 9:06 am | by Lindsey Tanner, AP Medical Writer | News | Comments

Teen girls who have sex should use IUDs or hormonal implants — long-acting birth control methods that are effective, safe and easy to use, the nation's most influential pediatricians' group recommends. In an updated policy, the American Academy...

First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. Over-the-Counter Sales

September 25, 2014 9:56 am | by Rinovum Women’s Health | News | Comments

Rinovum Women’s Health announced today that The Stork OTC—the only home-use conception assistance device on the market cleared by the FDA for over-the-counter sales—is available without a prescription in stores and online at the company's...

Advertisement

New Fertility Test for Assessment of Ovarian Reserve for Pregnancy

September 19, 2014 2:41 pm | by Roche | News | Comments

Roche today announced the launch of the Elecsys Anti-Müllerian Hormone (AMH) blood test, the first fully-automated AMH test for assessing a woman’s ovarian reserve. AMH is an important fertility marker used by healthcare professionals to...

Photos of the Day: 4D Ultrasound Enables a Prenatal View

September 18, 2014 9:34 am | by GE Healthcare | News | Comments

There were people who thought that Italian priest and scientist Lazzaro Spallanzani had bats in the belfry. But he had bats on his mind. Working in the late 1700s, Spallanzani showed that blindfolded bats could still catch flies...

Philips Showcases Ultrasound Innovations that Address Clinical Challenges in the OB/GYN Segment

September 15, 2014 9:39 am | by The Associated Press | News | Comments

Royal Philips has announced that its growing range of advanced women's healthcare imaging solutions will be showcased at the 24th annual International Society for Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress, taking place...

Automated Anti-Müllerian Hormone Test to Improve Fertility Assessment and Treatment

September 11, 2014 9:29 am | by Beckman Coulter | News | Comments

Beckman Coulter Diagnostics has obtained CE Mark on its new automated Access anti-Müllerian hormone (AMH) assay. The new test is the company’s latest innovation in women’s health testing and further advances Beckman Coulter’s rich 15-year...

New Single-Size Contraceptive Diaphragm in the US

September 9, 2014 11:04 am | by PATH | News | Comments

The United States Food and Drug Administration (USFDA) has cleared the Caya contoured diaphragm for marketing in the United States, bringing women one step closer to a new option for safe and effective non-hormonal contraception. The Caya contoured...

Advertisement

New Blood Test Could Offer More Tailored Treatment of Ovarian Cancer

September 5, 2014 10:01 am | by Manchester University | News | Comments

A new blood test allowing doctors to predict which ovarian cancer patients will respond to particular types of treatment is a step closer following a new study by Manchester scientists. Researchers from The University of Manchester and The...

Design Innovation vs. The ‘What If?’

August 22, 2014 2:03 pm | by Sean Fenske, Editor-In-Chief | Blogs | Comments

There are many obstacles to a successful product design getting into the marketplace (in the medical device space, some would argue that the FDA needlessly creates even more, however, that’s for another day’s discussion). Therefore, designers...

FDA 510(k) Clearance for Philips’ Ultra Mobile VISIQ Ultrasound System

July 24, 2014 12:15 pm | by PR Newswire | News | Comments

Royal Philips has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the first Philips ultrasound system to combine...

Why Remote-Controlled Birth Control Will Be the Next Big Thing

July 22, 2014 3:31 pm | by Kasey Panetta, Managing Editor, ECN | Blogs | Comments

In the midst of the Hobby Lobby court case decision and other conversations about birth control, there has been an announcement about an advancement in contraceptive technology. This is a pretty unique technology that would allow the woman...

Sagentia Partners with Premaitha Health to Develop Non-Invasive Diagnostic for Prenatal Screening

July 21, 2014 9:41 am | by Sagentia | News | Comments

Sagentia, a leading global science, technology & product development company, is working with Premaitha Health, a molecular diagnostics company based in Manchester UK, to develop Premaitha’s IONA test. It will be the first complete non...

Advertisement

Why Contraception by Remote Control Is a Troubling Idea

July 14, 2014 10:41 am | by Chris Warner, Executive Editor, ECN | Blogs | Comments

Forget about remembering to take a contraceptive pill. In just a few years, keeping track of your remote control may be as essential to family planning as it is to watching TV. MicroCHIPS, a small, Massachusetts company with backing from Bill Gates...

Making Embryos from Three People Doesn't Look Unsafe

June 3, 2014 3:58 pm | by Maria Cheng, AP Medical Writer | News | Comments

Britain's fertility regulator says controversial techniques to create embryos from the DNA of three people "do not appear to be unsafe" even though no one has ever received the treatment, according to a new report released Tuesday. The report...

Precision-Guided Epidurals and Better Blood Monitors

May 28, 2014 9:23 am | by The Optical Society | News | Comments

The march of modern medicine is often driven by revolutions in medical imaging. When technology advances, doctors are better able to peer deeply into human tissues, and thus able to detect, diagnose and treat human diseases more effectively...

Regulations Driving Adoption of Non-Phthalate Materials for Medical Tubing

May 27, 2014 3:25 pm | by Mark Brucks, Market Development Representative, Eastman Chemical Company | Articles | Comments

With increasing pressure on device manufacturers to move away from DEHP in PVC, OEMs are seeking a plasticizer option that performs similarly without the related, potential health concerns. This article examines the trend, the regulations...

Canada Funds 65 Innovative Health Projects to Help Save Every Woman, Every Child

May 22, 2014 8:30 am | by Grand Challenges Canada | News | Comments

Grand Challenges Canada, funded by the Government of Canada, today announces investments of $12 million in projects worldwide, aimed squarely at improving the health and saving the lives of mothers, newborns and children in developing countries...

Boston Scientific to Acquire IoGyn Inc.

May 7, 2014 11:42 am | by Boston Scientific | News | Comments

Boston Scientific Corporation has signed a definitive agreement to acquire IoGyn, Inc., a pre-commercial stage company. The transaction is expected to close within days. IoGyn has developed and received U.S. Food and Drug Administration...

Endo to Pay $830M to Settle Pelvic Mesh Lawsuits

April 30, 2014 6:31 pm | by The Associated Press | News | Comments

Drug and medical device maker Endo International says it will pay $830 million to resolve roughly 20,000 personal lawsuits from patients who say they were injured by the company's vaginal mesh implants. The Irish company said in a statement...

J&J Halts Sale of Electric Fibroid Removal Devices

April 30, 2014 12:36 pm | by The Associated Press | News | Comments

Johnson & Johnson is halting sales of devices used to remove growths in the uterus following a government warning that the electronic surgical tools can inadvertently spread cancer to other parts of the body. The announcement comes one...

FDA Addresses Surgical Mesh Risks for Transvaginal Repair of Pelvic Organ Prolapse

April 29, 2014 10:16 am | by FDA | News | Comments

The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify surgical...

FDA Approves First Human Papillomavirus Test for Primary Cervical Cancer Screening

April 25, 2014 9:56 am | by FDA | News | Comments

The U.S. Food and Drug Administration today approved the first FDA-approved HPV DNA test for women 25 and older that can be used alone to help a health care professional assess the need for a woman to undergo additional diagnostic testing...

FDA Warns of Cancer Risk with Fibroid Procedure

April 17, 2014 4:41 pm | by Matthew Perrone - AP Health Writer | News | Comments

The Food and Drug Administration is warning women that a surgical procedure to remove noncancerous growths from the uterus could inadvertently spread cancer to other parts of the body. The agency is discouraging doctors from performing the...

DNA Alternative to Pap Smear Sparks Medical Debate

April 15, 2014 1:53 pm | by Matthew Perrone, AP Health Writer | News | Comments

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear. The new...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading